Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Aadi Bioscience Inc shares valued at $18,797 were sold by Lennon David James on Oct 03 ’24. At $1.94 per share, Lennon David James sold 9,689 shares. The insider’s holdings dropped to 22,869 shares worth approximately $52141.31999999999 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lennon David James purchased 9,689 shares, netting a total of over 18,797 in proceeds.
Before that, Desai Neil had sold 40,000 shares from its account. In a trade valued at $68,316, the EXECUTIVE CHAIRMAN traded Aadi Bioscience Inc shares for $1.71 each. Upon closing the transaction, the insider’s holdings decreased to 40,000 shares, worth approximately $2.67 million.
As published in a research note from Piper Sandler on August 27, 2024, Aadi Bioscience Inc [AADI] has been rated down from an Overweight to a Neutral and the price target has been revised to $1.75 from $5. Analysts at TD Cowen downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late August. As of August 21, 2024, Jefferies has decreased its “Buy” rating to a “Hold” for AADI. Earlier on December 15, 2023, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for AADI stock which previously was a “a Buy”.
Analyzing AADI Stock Performance
During the last five days, there has been a surge of approximately 2.70%. Over the course of the year, Aadi Bioscience Inc shares have jumped approximately 12.87%. Shares of the company reached a 52-week high of $2.47 on 03/04/24 and a 52-week low of $1.21 on 08/08/24. A 50-day SMA is recorded $2.06, while a 200-day SMA reached $1.86. Nevertheless, trading volume fell to 77725.0 shares from 0.38 million shares the previous day.
Support And Resistance Levels for Aadi Bioscience Inc (AADI)
According to the 24-hour chart, there is a support level at 2.24, which, if violated, would cause prices to drop to 2.21. In the upper region, resistance lies at 2.35. The next price resistance is at 2.42. RSI (Relative Strength Index) is 62.55 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.07, which suggests the price will decrease in the coming days. Percent R is at 28.57%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
